Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1979 1
1980 2
1982 2
1984 3
1999 1
2001 2
2002 2
2003 1
2004 2
2005 2
2006 4
2007 3
2008 6
2009 1
2010 3
2011 3
2012 5
2013 3
2014 5
2015 2
2016 5
2018 3
2019 10
2020 12
2021 16
2022 11
2023 11
2024 21
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment.
Yabushita T, Chinen T, Nishiyama A, Asada S, Shimura R, Isobe T, Yamamoto K, Sato N, Enomoto Y, Tanaka Y, Fukuyama T, Satoh H, Kato K, Saitoh K, Ishikawa T, Soga T, Nannya Y, Fukagawa T, Nakanishi M, Kitagawa D, Kitamura T, Goyama S. Yabushita T, et al. Among authors: chinen t. Cell Rep. 2023 Sep 26;42(9):113098. doi: 10.1016/j.celrep.2023.113098. Epub 2023 Sep 14. Cell Rep. 2023. PMID: 37714156 Free article.
Molecular basis promoting centriole triplet microtubule assembly.
Takeda Y, Chinen T, Honda S, Takatori S, Okuda S, Yamamoto S, Fukuyama M, Takeuchi K, Tomita T, Hata S, Kitagawa D. Takeda Y, et al. Among authors: chinen t. Nat Commun. 2024 Mar 22;15(1):2216. doi: 10.1038/s41467-024-46454-x. Nat Commun. 2024. PMID: 38519454 Free PMC article.
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study.
Sato S, Ssuzuki T, Chinen T, Yamaguchi H, Suzuki Y, Hokamura N, Saze Z, Kono K, Takahashi K, Yano F, Kunisaki C, Kosaka T, Endo I, Ichikawa Y, Miyawaki Y, Sato H, Shimada H. Sato S, et al. Among authors: chinen t. Int J Clin Oncol. 2024 Jul;29(7):994-1001. doi: 10.1007/s10147-024-02532-0. Epub 2024 Apr 28. Int J Clin Oncol. 2024. PMID: 38679627
Large Lung Abscess Caused by Fusobacterium nucleatum.
Kami W, Baba M, Chinen T, Fujita J. Kami W, et al. Among authors: chinen t. Intern Med. 2023 Dec 15;62(24):3721. doi: 10.2169/internalmedicine.1751-23. Epub 2023 Apr 21. Intern Med. 2023. PMID: 37081680 Free PMC article. No abstract available.
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases.
Sato S, Suzuki T, Chinen T, Yamaguchi H, Suzuki Y, Hokamura N, Saze Z, Kono K, Takahashi K, Yano F, Sato T, Kosaka T, Endo I, Ichikawa Y, Miyawaki Y, Sato H, Shimada H. Sato S, et al. Among authors: chinen t. J Gastroenterol. 2024 Nov;59(11):979-985. doi: 10.1007/s00535-024-02141-8. Epub 2024 Aug 17. J Gastroenterol. 2024. PMID: 39153106
A New 1,2-Naphthoquinone Derivative with Anti-lung Cancer Activity.
Nakagawa R, Tateishi H, Radwan MO, Chinen T, Ciftci H, Iwamaru K, Baba N, Tominaga Y, Koga R, Toma T, Inoue JI, Umezawa K, Fujita M, Otsuka M. Nakagawa R, et al. Among authors: chinen t. Chem Pharm Bull (Tokyo). 2022;70(7):477-482. doi: 10.1248/cpb.c21-01087. Chem Pharm Bull (Tokyo). 2022. PMID: 35786566 Free article.
An essential role for the IL-2 receptor in Treg cell function.
Chinen T, Kannan AK, Levine AG, Fan X, Klein U, Zheng Y, Gasteiger G, Feng Y, Fontenot JD, Rudensky AY. Chinen T, et al. Nat Immunol. 2016 Nov;17(11):1322-1333. doi: 10.1038/ni.3540. Epub 2016 Sep 5. Nat Immunol. 2016. PMID: 27595233 Free PMC article.
135 results